Andarine and S-23 both come up in the same conversations; they overlap on Skeletal muscle and Bone. Andarine: Andarine (S-4) is a non-steroidal selective androgen receptor modulator derived from arylpropionamide chemistry that binds the androgen receptor with high affinity yet acts in a tissue-selective manner. S-23: S-23 is a high-affinity, orally active selective androgen receptor modulator (SARM) first characterized as a candidate for hormonal male contraception.
Andarine (S-4) is a non-steroidal selective androgen receptor modulator derived from arylpropionamide chemistry that binds the androgen receptor with high affinity yet acts in a tissue-selective manner. In castrated and ovariectomized rodents it restored skeletal muscle mass and strength, raised bone mineral density, and reduced body fat while stimulating the prostate and seminal vesicles far less than dihydrotestosterone; this partial-agonist behavior in androgenic organs versus full-agonist activity in muscle and bone defines the SARM concept. Its favorable pharmacokinetics, including high oral bioavailability and predominantly hepatic phase I and II metabolism, once positioned it as a clinical candidate for muscle wasting and osteoporosis. It was never approved for human use, however, and is prohibited in sport, so it is documented largely through preclinical pharmacology and anti-doping detection studies rather than clinical trials.
S-23 is a high-affinity, orally active selective androgen receptor modulator (SARM) first characterized as a candidate for hormonal male contraception. It binds the androgen receptor as a full agonist and, in animal studies, builds lean muscle mass and bone mineral density while cutting fat, a tissue-selective anabolic profile that has drawn strong interest for body recomposition. It also potently and reversibly suppresses testosterone and sperm production, which is central to both its contraceptive rationale and its cautions.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Selective partial agonist
High-affinity selective agonist
DHT antagonism
Anabolic stimulation
Suppression
Reduction
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.